Skip to content

Hope for chronically suicidal patient: evaluating the clinical and health services impact of dialectical behaviour therapy (DBT) in individuals with borderline personality disorder

Evaluating the clinical and health services impact of dialectical behaviour therapy (DBT) in individuals with borderline personality disorder: a randomised controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN02634417
Enrollment
180
Registered
2005-11-16
Start date
2002-10-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Borderline personality disorder (BPD) Mental and Behavioural Disorders Schizotypal disorder

Interventions

1. Dialectical behaviour therapy (Linehan, 1993) 2. General Psychiatric Management based on the American Psychiatric Association (APA) practice guidelines Trial details received: 12 Sept 2005

Sponsors

The Centre for Addiction and Mental Health (Toronto) (Canada)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Meet Diagnostic and Statistical Manual of Mental Disorders, Fourth edition (DSM-IV) criteria for BPD 2. Be between 18 - 60 years of age, either sex 3. Have had two Para-suicide episodes in the past 5 years with one occurring in the past 3 months 4. Have had OHIP insurance coverage for 1 year or more 5. Be literate in English 6. Provide informed consent to participate in study 7. Agree to be compliant with prescribed psychotropic medication(s)

Exclusion criteria

Exclusion criteria: 1. Current active substance dependence disorder 2. Psychotic disorder, bipolar or dementia 3. Evidence of an organic brain syndrome or mental retardation 4. Chronic or serious physical health problem that may require hospitalisation with the next year 5. Medical condition that would preclude the psychiatric medication regimen 6. Currently engaged in DBT or in GPM at St Michael's Hospital

Design outcomes

Secondary

MeasureTime frame
1. Psychiatric hospitalisation 2. Psychiatric symptoms 3. Anger 4. Treatment retention 5. Social functioning

Primary

MeasureTime frame
Parasuicidal behaviour

Countries

Canada

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026